Levodopa for the treatment of Parkinson's disease.
Lewitt
Peter A
PA
Department of Neurology, Henry Ford Hospital, and the Department of Neurology, Wayne State University School of Medicine, Detroit, USA. palewitt@ameritech.net
D000978:Antiparkinson Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001921:Brain / Q000378:metabolism; D001933:Brain Stem / Q000473:pathology; D004298:Dopamine / Q000096:biosynthesis*; D006801:Humans; D007980:Levodopa / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009474:Neurons / Q000378:metabolism; D010300:Parkinson Disease / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D017410:Practice Guidelines as Topic
D000978:Antiparkinson Agents; D007980:Levodopa; D004298:Dopamine